Zhaonan Yu
Hangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
CEP55-associated lethal fetal syndrome: a case report of a Chinese family.
Journal: Frontiers in genetics
Published: August 07, 2023
EGFR co-mutation is associated with the risk of recurrence in invasive lung adenocarcinoma with the micropapillary component.
Journal: Asian journal of surgery
Published: January 30, 2023
Carbonic Anhydrase 4 Serves as A Novel Prognostic Biomarker and Therapeutic Target for Non-Small Cell Lung Cancer: A Study Based on TCGA Samples.
Journal: Combinatorial chemistry & high throughput screening
Published: November 25, 2022
Microbiota profiles in the saliva, cancerous tissues and its companion paracancerous tissues among Chinese patients with lung cancer.
Journal: BMC microbiology
Published: September 15, 2022
Composition of the Gut Microbiota Associated with the Response to Immunotherapy in Advanced Cancer Patients: A Chinese Real-World Pilot Study.
Journal: Journal of clinical medicine
Published: August 16, 2022
A comprehensive analysis of the microbiota composition and host driver gene mutations in colorectal cancer.
Journal: Investigational new drugs
Published: March 21, 2022
Atypical pneumonia caused by Chlamydia psittaci during the COVID-19 pandemic.
Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: March 08, 2022
Identifification of a novel LDLR-RET Fusion in Lung Adenocarcinoma.
Journal: Investigational new drugs
Published: February 07, 2022
Genomic Alteration Spectrum of Non-Small Cell Lung Cancer Patients in East-China Characterized by Tumor Tissue DNA and Cell-Free DNA.
Journal: OncoTargets and therapy
Published: November 24, 2021
A novel RET fusion in non-small cell lung cancer identified by next-generation sequencing: a case report.
Journal: Journal of cancer research and clinical oncology
Published: November 23, 2021
A novel 3' truncated ALK cause ALK + in a patient with minimally invasive adenocarcinoma.
Journal: Journal of cancer research and clinical oncology
Published: May 26, 2021
A novel 5'ALK fusion identified by next generation sequencing and validated by IHC in a patient with lung adenocarcinoma.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: May 24, 2021
Last Updated: 09/26/2026